Clinical Case of Primary Ovarian Osteosarcoma
DOI:
https://doi.org/10.15407/exp-oncology.2026.01.051Keywords:
ovarian cancer, osteosarcoma of the ovary, osteosarcoma, teratomaAbstract
We describe an extremely rare clinical case of primary ovarian osteosarcoma (OS) in a 70-year-old woman, along with the diagnostic criteria for this condition. The patient underwent chemotherapy and has been under observation for 27 months. Currently, tumor progression with metastatic lesions of the peritoneum is observed. This case highlights the importance of further studies of primary ovarian OS. Ovarian OS is not included in the 2022 WhO classification of genital tumors, but such cases occur; their diagnosis is difficult, and there is no consensus on the treatment. Accumulat- ing data on the structural features of these tumors and their response to treatment will help improve the understanding of their treatment.
References
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229-263. https://doi.org/10.3322/caac.21834
Lacoste C, Cormier B, Marret H, et al. Primary osteosarcoma of the ovary. Gynecol Obstet Fertil. 2015;43(7-8):555-556. https://doi.org/10.1016/j.gyobfe.2015.06.001
Hauben EI, Weeden S, Pringle J, et al. Does the histological subtype of high-grade central osteosarcoma influence the response to treatment with chemotherapy, and does it affect overall survival? A study on 570 patients of two consecutive trials of the European Osteosarcoma Intergroup. Eur J Cancer. 2002;38(9):1218-1225. https://doi.org/10.1016/s0959-8049(02)00037-0
Machado I, Navarro S, Picci P, et al. The utility of SATB2 immunohistochemical expression in distinguishing between osteosarcomas and their malignant bone tumor mimickers, such as Ewing sarcomas and chondrosarcomas. Pathol Res Pract. 2016;212(9):811-816. https://doi.org/10.1016/j.prp.2016.06.012
Hines JF, Compton DM, Stacy CC, et al. Pure primary osteosarcoma of the ovary presenting as an extensively calcified adnexal mass: a case report and review of the literature. Gynecol Oncol. 1990;39(3):259-263. https://doi.org/10.1016/0090-8258(90)90248-j
Fadare O, Bossuyt V, Martel M, et al. Primary osteosarcoma of the ovary: a case report and literature review. Int J Gynecol Pathol. 2007;26(1):21-25. https://doi.org/10.1097/01.pgp.0000225840.36750.a2
Siegel MJ, McAlister WH, Shackelford GD. Radiographic findings in ovarian teratomas in children. AJR Am J Roentgenol. 1978;131(4):613-615. https://doi.org/10.2214/ajr.131.4.613
Vyas V, Rammah AM, Ashebu SD, et al. A case report of primary osteosarcoma of the ovary. Int J Gynecol Cancer. 2006;16(Suppl 1):349-352. https://doi.org/10.1111/j.1525-1438.2006.00485.x
Yeasmin S, Nakayama K, Ishibashi M, et al. Primary osteosarcoma of the ovary. Int J Clin Oncol. 2009;14(2):163-166. https://doi.org/10.1007/s10147-008-0807-x
National Comprehensive Cancer Network. Bone cancer (Version 1.2025) [Internet]. Plymouth Meeting (PA): NCCN; 2024 Aug 20 [cited 2024 Aug 29]. Available from: https://www.nccn.org/professionals/physician_gls/pdf/bone.pdf
Strauss SJ, Frezza AM, Abecassis N, et al. Bone sarcomas: ESMO-EURACAN-GENTURIS-ERN PaedCan Clinical Practice Guideline for diagnosis, treatment, and follow-up. Ann Oncol. 2021;32(12):1520-1536. https://doi.org/10.1016/j.annonc.2021.08.1995
Valery PC, Laversanne M, Bray F. Bone cancer incidence by morphological subtype: a global assessment. Cancer Causes Control. 2015;26(8):1127-1139. https://doi.org/10.1007/s10552-015-0607-3
Bramwell VH, Steward WP, Nooij M, et al. Neoadjuvant chemotherapy with doxorubicin and cisplatin in malignant fibrous histiocytoma of bone: A European Osteosarcoma Intergroup study. J Clin Oncol. 1999;17(10):3260-3267. https://doi.org/10.1200/JCO.1999.17.10.3260
Rosen G, Marcove RC, Huvos AG, et al. Primary osteogenic sarcoma: eight-year experience with adjuvant chemotherapy. J Cancer Res Clin Oncol. 1983;106(Suppl):55-67. https://doi.org/10.1007/BF00625054
Bacci G, Picci P, Ferrari S, et al. Primary chemotherapy and delayed surgery for non-metastatic osteosarcoma of the extremities. Results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin. Cancer. 1993;72(11):3227-3238. https://doi.org/10.1002/1097-0142(19931201)72:11<3227::aid-cncr2820721116>3.0.co;2-c
WHO Classification of Tumours Editorial Board. Soft tissue and bone tumours [Internet]. Lyon (France): International Agency for Research on Cancer; 2020 [cited 2024 Aug 29]. (WHO classification of tumours series, 5th ed.; vol. 3). Available from: https://publications.iarc.fr/588
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Experimental Oncology
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
